Bupropion occupancy of the dopamine transporter is low during clinical treatment.

Article Details

Citation
Copy to clipboard

Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

Psychopharmacology (Berl). 2002 Aug;163(1):102-5. Epub 2002 Jul 13.

PubMed ID
12185406 [ View in PubMed
]
Abstract

RATIONALE: Bupropion is thought to treat major depression by blocking the dopamine transporter (DAT) because bupropion appears to have a selective affinity for the DAT. The validity of this mechanism has been questioned because the affinity of bupropion for the DAT is quite low. OBJECTIVE: To determine the occupancy of bupropion for the DAT during clinical treatment of patients with depression. METHODS: Positron emission tomography with [(11)C]-RTI32 was used to determine the striatal DAT binding potential (BP) of eight depressed patients before and during treatment with bupropion. BP is proportional to available receptor density (receptors not blocked by drug). Occupancy is the percent change in BP. Eight healthy subjects were similarly studied in a test-retest design. RESULTS: No significant difference in DAT BP was found after bupropion treatment in comparison to the test-retest data. The occupancy after bupropion treatment was 14% (confidence interval 6-22%) as compared to 7% in the test-retest condition. CONCLUSIONS: Bupropion treatment occupies less than 22% of DAT sites. This raises the question as to whether a DAT occupancy of less than 22% is therapeutic or whether there is another mechanism involved during treatment with bupropion.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
BupropionSodium-dependent dopamine transporterProteinHumans
Yes
Inhibitor
Details
Drug Interactions
DrugsInteraction
Integrate drug-drug
interactions in your software
Ioflupane I-123
Bupropion		Bupropion may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.